{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:21:07Z","timestamp":1787847667790,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.4103\/0028-3886.314567","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T01:30:50Z","timestamp":1619400650000},"page":"437-438","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Drug-Induced Parkinsonism"],"prefix":"10.4103","volume":"69","author":[{"given":"Kanwaljeet","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-41-20240907","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.4103\/0028-3886.226459","article-title":"Parkinsonian syndromes: A review","volume":"66","author":"Srivanitchapoom","year":"2018","journal-title":"Neurol India"},{"key":"R2-41-20240907","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J Clin Neurol"},{"key":"R3-41-20240907","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00007611-199005000-00011","article-title":"Neurologic approach to drug-induced movement disorders: A study of 125 patients","volume":"83","author":"Miller","year":"1990","journal-title":"South Med J"},{"key":"R4-41-20240907","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1472-8206.1994.tb00808.x","article-title":"Drug-induced parkinsonism: A review","volume":"8","author":"Montastruc","year":"1994","journal-title":"Fundam Clin Pharmacol"},{"key":"R5-41-20240907","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2001-13120","article-title":"Movement disorders induced by dopamine blocking agents","volume":"21","author":"Sethi","year":"2001","journal-title":"Semin Neurol"},{"key":"R6-41-20240907","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3988\/jcn.2012.8.1.15","article-title":"Drug-induced parkinsonism","volume":"8","author":"Shin","year":"2012","journal-title":"J Clin Neurol"},{"key":"R7-41-20240907","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mds.20806","article-title":"Parkinsonism and Parkinson's disease in the elderly: A community-based survey in Brazil (the Bambu\u00ed study)","volume":"21","author":"Barbosa","year":"2006","journal-title":"Mov Disord"},{"key":"R8-41-20240907","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0028-3886.198175","article-title":"Drug-induced Parkinsonism on the rise: Beware of levosulpiride and its combinations with proton pump inhibitors","volume":"65","author":"Mathew","year":"2017","journal-title":"Neurol India"},{"key":"R9-41-20240907","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00002826-198300061-00004","article-title":"Neuroleptic-induced extrapyramidal reactions: Classification, description, and diagnosis","volume":"6","author":"Tarsy","year":"1983","journal-title":"Clin Neuropharmacol"},{"key":"R10-41-20240907","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/mds.870130313","article-title":"Cinnarizine-induced parkinsonism: ten years later","volume":"13","author":"Mart\u00ed-Mass\u00f3","year":"1998","journal-title":"Mov Disord"},{"key":"R11-41-20240907","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2006.09.019","article-title":"Pregabalin action at a model synapse: Binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice","volume":"553","author":"Joshi","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R12-41-20240907","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/WNF.0b013e3181a9eb1b","article-title":"Pregabalin-induced parkinsonism: A case report","volume":"32","author":"Perez Lloret","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"R13-41-20240907","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/pgmj.2008.073312","article-title":"Drug induced parkinsonism: A common cause of parkinsonism in older people","volume":"85","author":"Thanvi","year":"2009","journal-title":"Postgrad Med J"},{"key":"R14-41-20240907","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/mds.23828","article-title":"Drug-induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France","volume":"26","author":"Bondon-Guitton","year":"2011","journal-title":"Mov Disord"},{"key":"R15-41-20240907","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/FPC.0b013e3282f70492","article-title":"Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced, treatment-resistant tardive dyskinesia","volume":"18","author":"Inada","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"R16-41-20240907","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(77)90429-9","article-title":"Oestrogens and extrapyramidal system","volume":"2","author":"Bedard","year":"1977","journal-title":"Lancet"},{"key":"R17-41-20240907","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.21854","article-title":"Failure of recognition of drug-induced parkinsonism in the elderly","volume":"23","author":"Esper","year":"2008","journal-title":"Mov Disord"},{"key":"R18-41-20240907","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.4103\/0028-3886.226460","article-title":"Neuroimaging in parkinsonian disorders","volume":"66","author":"Tripathi","year":"2018","journal-title":"Neurol India"},{"key":"R19-41-20240907","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/mds.10592","article-title":"Role of dopamine transporter imaging in routine clinical practice","volume":"18","author":"Marshall","year":"2003","journal-title":"Mov Disord"},{"key":"R20-41-20240907","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2377-7-27","article-title":"Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes","volume":"7","author":"Vlaar","year":"2007","journal-title":"BMC Neurol"},{"key":"R21-41-20240907","first-page":"102","article-title":"The sensitivity and specificity of F-DOPA PET in a movement disorder clinic","volume":"6","author":"Ibrahim","year":"2016","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["Neurology India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.314567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:27:12Z","timestamp":1787844432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0028-3886.314567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/0028-3886.314567","relation":{},"ISSN":["0028-3886"],"issn-type":[{"value":"0028-3886","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}